选择性菌体减少了在菌体-抗生素联合治疗中耐药细菌的出现
Aa Haeruman Azam1, Koji Sato2, Kazuhiko Miyanaga2,3
1Therapeutic Drugs and Vaccine Development Research Center, National Institute of Infectious Diseases, Toyama-ku, Shinjuku, Tokyo, Japan.
Microbiology spectrum
|May 2, 2024
概括
与氏菌素和细菌菌体的联合治疗对抗大肠杆菌O157.7具有前景. 然而,仔细的菌体选择至关重要,因为一些菌体可以通过选择特定的基因突变无意中增加抗生素耐药性.
科学领域:
- 微生物学 微生物学
- 食品安全 食品安全
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 大肠杆菌Escherichia coli O157:H7是一种重要的食物传播病原体.
- 大肠杆菌O157:H7的抗生素耐药性是一个越来越令人担忧的问题.
- 需要新的治疗策略来对抗感染.
研究的目的:
- 为了比较抗生素和细菌体单一疗法的疗效与对抗大肠杆菌O157:H7.7.的组合疗法的疗效.
- 研究抗药性发展的机制.
- 识别影响耐药性的菌体和细菌因素.
主要方法:
- 用菌体和抗生素进行持续暴露实验.
- 针对特定基因 (glpT, uhpT, ompC) 的遗传删除研究.
- 对细菌体PP01和SP15的受体利用的分析.
主要成果:
- 与单一治疗相比,组合疗法显示出更好的杀菌效果.
- 删除glpT和uhpT增加了对氏菌素的耐药性.
- 体PP01使用OmpC作为受体;SP15使用FhuA.
- 在glpT/uhpT突变体中删除ompC进一步增加了氏素耐药性.
- 特定的菌体可以选择对菌体和抗生素产生抵抗力的突变.
结论:
- 福斯福米辛和细菌菌体的联合治疗对大肠杆菌O157.7有效.
- 菌体选择对于避免抗生素耐药性的出现至关重要.
- 某些菌体选择的突变可以增强抗生素耐药性,需要在组合疗法中谨慎选择菌体.
关键词:
O157:H7 7 的时间.抗微生物药物 抗微生物药物细菌治疗是一种细菌治疗.腹 腹 腹 腹 腹 腹 腹 腹药物耐药性的演变 药物耐药性的演变药物耐药性机制 抗药性机制这种药物是斯福米辛 (phosfomycin).我们的肠道微生物群.外膜蛋白质的外部膜蛋白质.更多相关视频
相关概念视频
Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
Antibiotic Selection
53.3K
Overview
53.3K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Lysogenic Cycle of Bacteriophages
62.1K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.1K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


